Search Results

There are 3592 results for: content related to: Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: The role of acute-phase reactants

  1. Tocilizumab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Jasvinder A Singh, Saba Beg and Maria Angeles Lopez-Olivo

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD008331.pub2

  2. You have free access to this content
    Exposure-Exposure Relationship of Tocilizumab, an Anti–IL-6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis

    The Journal of Clinical Pharmacology

    Volume 53, Issue 2, February 2013, Pages: 151–159, Micha Levi, Susan Grange and Nicolas Frey

    Version of Record online : 22 FEB 2013, DOI: 10.1177/0091270012437585

  3. Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study

    International Journal of Rheumatic Diseases

    Volume 19, Issue 11, November 2016, Pages: 1093–1102, Tristan Pascart, Peggy Philippe, Elodie Drumez, Xavier Deprez, Bernard Cortet, Alain Duhamel, Eric Houvenagel and René-Marc Flipo

    Version of Record online : 27 MAR 2016, DOI: 10.1111/1756-185X.12845

  4. Infliximab is equivalently suppressing oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis

    International Journal of Rheumatic Diseases

    Kazuha Kizaki, Fumiharu Yamashita, Tomoya Hayashi and Noboru Funakoshi

    Version of Record online : 24 OCT 2016, DOI: 10.1111/1756-185X.12972

  5. You have free access to this content
    Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year

    Arthritis & Rheumatism

    Volume 63, Issue 3, March 2011, Pages: 609–621, Joel M. Kremer, Ricardo Blanco, Marek Brzosko, Ruben Burgos-Vargas, Anne-Marie Halland, Emma Vernon, Petra Ambs and Roy Fleischmann

    Version of Record online : 25 FEB 2011, DOI: 10.1002/art.30158

  6. You have full text access to this OnlineOpen article
    Mechanism-based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study)

    The Journal of Clinical Pharmacology

    Volume 54, Issue 1, January 2014, Pages: 109–119, Shuji Ohta, Tomomi Tsuru, Kimio Terao, Seiji Mogi, Midori Suzaki, Eisuke Shono, Yoshimasa Ishida, Eriko Tarumi and Masato Imai

    Version of Record online : 12 OCT 2013, DOI: 10.1002/jcph.185

  7. You have full text access to this OnlineOpen article
    Evaluation of the Disease Activity Score in Twenty-Eight Joints–Based Flare Definitions in Rheumatoid Arthritis: Data From a Three-Year Clinical Trial

    Arthritis Care & Research

    Volume 67, Issue 12, December 2015, Pages: 1762–1766, Maxime Dougados, Tom W. J. Huizinga, Ernest H. Choy, Clifton O. Bingham III, Maher Aassi and Corrado Bernasconi

    Version of Record online : 24 NOV 2015, DOI: 10.1002/acr.22633

  8. You have free access to this content
    Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

    Arthritis & Rheumatism

    Volume 54, Issue 9, September 2006, Pages: 2817–2829, R. N. Maini, P. C. Taylor, J. Szechinski, K. Pavelka, J. Bröll, G. Balint, P. Emery, F. Raemen, J. Petersen, J. Smolen, D. Thomson and T. Kishimoto

    Version of Record online : 31 AUG 2006, DOI: 10.1002/art.22033

  9. You have free access to this content
    Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

    Arthritis & Rheumatism

    Volume 58, Issue 10, October 2008, Pages: 2968–2980, Mark C. Genovese, James D. McKay, Evgeny L. Nasonov, Eduardo F. Mysler, Nilzio A. da Silva, Emma Alecock, Thasia Woodworth and Juan J. Gomez-Reino

    Version of Record online : 29 SEP 2008, DOI: 10.1002/art.23940

  10. You have full text access to this OnlineOpen article
    Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis

    Arthritis Care & Research

    Volume 67, Issue 10, October 2015, Pages: 1354–1362, Atsushi Ogata, Tatsuya Atsumi, Takaaki Fukuda, Yasuhiko Hirabayashi, Masaaki Inaba, Naoki Ishiguro, Motokazu Kai, Daisuke Kawabata, Daihei Kida, Hitoshi Kohsaka, Ryutaro Matsumura, Seiji Minota, Masaya Mukai, Takayuki Sumida, Kiyoshi Takasugi, Shigenori Tamaki, Tsutomu Takeuchi, Atsuhisa Ueda, Kazuhiko Yamamoto, Hisashi Yamanaka, Hajime Yoshifuji, Akira Nomura and the Musashi Study Investigators

    Version of Record online : 22 SEP 2015, DOI: 10.1002/acr.22598

  11. You have full text access to this OnlineOpen article
    Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA

    The Journal of Clinical Pharmacology

    Volume 57, Issue 4, April 2017, Pages: 459–468, Hisham Abdallah, Joy C. Hsu, Peng Lu, Scott Fettner, Xiaoping Zhang, Wendy Douglass, Min Bao, Lucy Rowell, Gerd R. Burmester and Alan Kivitz

    Version of Record online : 17 NOV 2016, DOI: 10.1002/jcph.826

  12. You have full text access to this OnlineOpen article
    Relationship Between Baseline and Early Changes in C-Reactive Protein and Interleukin-6 Levels and Clinical Response to Tocilizumab in Rheumatoid Arthritis

    Arthritis Care & Research

    Volume 68, Issue 6, June 2016, Pages: 882–885, Jianmei Wang, Jenny Devenport, Jason M. Low, Dale Yu and Elena Hitraya

    Version of Record online : 26 MAY 2016, DOI: 10.1002/acr.22765

  13. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Glen S Hazlewood, Cheryl Barnabe, George Tomlinson, Deborah Marshall, Daniel JA Devoe and Claire Bombardier

    Published Online : 29 AUG 2016, DOI: 10.1002/14651858.CD010227.pub2

  14. You have free access to this content
    ARA Scientific Posters

    Internal Medicine Journal

    Volume 43, Issue S2, May 2013, Pages: 9–33,

    Version of Record online : 23 APR 2013, DOI: 10.1111/imj.12141

  15. You have free access to this content
    Abstracts

    Internal Medicine Journal

    Volume 46, Issue S2, April 2016, Pages: 5–50,

    Version of Record online : 27 APR 2016, DOI: 10.1111/imj.13052

  16. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Amy S Mudano, Elizabeth Tanjong Ghogomu, Maria E Suarez-Almazor, Rachelle Buchbinder, Lara J Maxwell, Peter Tugwell and George A Wells

    Published Online : 8 MAY 2017, DOI: 10.1002/14651858.CD012657

  17. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Amy S Mudano, Lara J Maxwell, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Maria E Suarez-Almazor, Peter Tugwell and George A Wells

    Published Online : 10 MAR 2017, DOI: 10.1002/14651858.CD012591

  18. You have free access to this content
    In vivo effects of the anti–interleukin-6 receptor inhibitor tocilizumab on the B cell compartment

    Arthritis & Rheumatism

    Volume 63, Issue 5, May 2011, Pages: 1255–1264, Petra Roll, Khalid Muhammad, Mathias Schumann, Stefan Kleinert, Hermann Einsele, Thomas Dörner and Hans-Peter Tony

    Version of Record online : 27 APR 2011, DOI: 10.1002/art.30242

  19. You have free access to this content
    ARA Scientific Posters

    Internal Medicine Journal

    Volume 44, Issue S2, May 2014, Pages: 10–37,

    Version of Record online : 16 APR 2014, DOI: 10.1111/imj.12426

  20. You have free access to this content
    Down-titration and discontinuation strategies of tumor necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity

    Intervention Review

    The Cochrane Library

    Noortje van Herwaarden, Alfons A den Broeder, Wilco Jacobs, Aatke van der Maas, Johannes WJ Bijlsma, Ronald F van Vollenhoven and Bart(holomeus) JF van den Bemt

    Published Online : 29 SEP 2014, DOI: 10.1002/14651858.CD010455.pub2